PHOENIX, AZ, UNITED STATES, February 18, 2026 /EINPresswire.com/ — Precision Epigenomics Inc., a biotechnology company pioneering epigenetic technologies for early ...
SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and ...
Cell-free DNA (cfDNA) analysis is transforming precision medicine, offering a non-invasive window into the body, particularly in the context of cancer. This journal collection, hosted by npj Precision ...
At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (ILMN) today announced new customer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results